Clinical Background | Total (N = 4715) | Favorable glycemic control HbA1c < 7% (N = 2165) | Unfavorable glycemic control HbA1c ≥ 7% (N = 2550) | p value |
---|---|---|---|---|
Age (years) |  |  |  | < 0.001 |
Median (Q1, Q3) | 66.00 (59.00, 74.00) | 67.00 (59.00, 75.00) | 65.00 (58.00, 73.00) | Â |
Male | 2898 (61.50%) | 1381 (63.80%) | 1517 (59.50%) | 0.003 |
Stroke severity |  |  |  | < 0.001 |
Mild (eNIHSS < 5) | 3617 (76.70%) | 1604 (74.10%) | 2013 (78.90%) |  |
Moderate (eNIHSS 5–14) | 911 (19.30%) | 445 (20.60%) | 466 (18.30%) |  |
Severe (eNIHSS > 14) | 187 (4.00%) | 116 (5.40%) | 71 (2.80%) |  |
BMI (kg/m2) | Â | Â | Â | 0.903 |
Median (Q1, Q3) | 25.40 (23.15, 28.03) | 25.35 (23.24, 28.04) | 25.46 (23.08, 27.99) | Â |
Hypertension | 3961 (84.00%) | 1861 (86.00%) | 2100 (82.40%) | 0.001 |
Dyslipidemia | 2548 (54.00%) | 1148 (53.00%) | 1400 (54.90%) | 0.198 |
Atrial fibrillation | 432 (9.20%) | 236 (10.90%) | 196 (7.70%) | < 0.001 |
Coronary artery disease | 495 (10.50%) | 218 (10.10%) | 277 (10.90%) | 0.376 |
Congestive heart failure | 210 (4.50%) | 90 (4.20%) | 120 (4.70%) | 0.363 |
History of cancer | 243 (5.20%) | 128 (5.90%) | 115 (4.50%) | 0.030 |
Current smoker | 1384 (29.40%) | 604 (27.90%) | 780 (30.60%) | 0.043 |
Total cholesterol (mmol/L) |  |  |  | < 0.001 |
Median (Q1, Q3) | 4.56 (3.86, 5.31) | 4.48 (3.78, 5.23) | 4.64 (3.96, 5.39) | Â |
Triglyceride (mmol/L) |  |  |  | < 0.001 |
Median (Q1, Q3) | 1.55 (1.12, 2.21) | 1.46 (1.07, 2.08) | 1.62 (1.18, 2.31) | Â |
eGFR (mL/min/1.73 m2) | Â | Â | Â | 0.072 |
Median (Q1, Q3) | 75.58 (53.14, 96.42) | 74.68 (53.40, 94.70) | 76.32 (52.92, 97.62) | Â |
ALT (U/L) | Â | Â | Â | 0.660 |
Median (Q1, Q3) | 21.00 (16.00, 31.00) | 22.00 (16.00, 31.00) | 21.00 (16.00, 30.00) | Â |
SBP (mmHg) | Â | Â | Â | 0.689 |
Median (Q1, Q3) | 154.00 (141.42, 167.55) | 153.75 (141.14, 168.58) | 154.07 (141.75, 166.77) | Â |
DBP (mmHg) | Â | Â | Â | 0.161 |
Median (Q1, Q3) | 85.13 (78.70, 92.33) | 85.36 (78.74, 92.85) | 85.00 (78.68, 92.00) | Â |
Heart rate (bpm) | Â | Â | Â | 0.001 |
Median (Q1, Q3) | 74.71 (68.25, 80.87) | 74.25 (67.42, 80.31) | 75.12 (69.00, 81.50) | Â |
Beta blocker user | 557 (11.80%) | 282 (13.00%) | 275 (10.80%) | 0.018 |
Insulin user | 345 (7.30%) | 73 (3.40%) | 272 (10.40%) | < 0.001 |